HTMwire assessment
DDISmart (DDi) is an agentic AI platform for pharma and medical-device regulatory automation. Its agents automate dossier and technical-file compilation, labeling and IFU compliance, and Clinical Evaluation Report (CER) updates across FDA, EU MDR, and ISO 13485 pathways, shifting regulatory teams from doers to reviewers. The platform serves medical device manufacturers' regulatory teams rather than hospital HTM departments.
Agentic regulatory automation that moves device-manufacturer regulatory teams from authoring to reviewing across FDA, EU MDR, and ISO 13485.
HTMwire's independent read on the technology — not the vendor's marketing claim.
DDISmart describes a 'REGai Automation & Agentic AI' platform whose autonomous agents execute regulatory processes, monitor status, escalate issues, and learn over time — automating dossier compilation, labeling QC, and CER updates so regulatory teams shift from doers to reviewers.
DDISmart (DDi) is an agentic AI platform for pharma and medical-device regulatory automation, handling dossier and technical-file compilation, labeling and IFU compliance, and Clinical Evaluation Report (CER) updates across FDA, EU MDR, and ISO 13485.
No. DDISmart is aimed at medical device manufacturers' regulatory teams, not hospital HTM or clinical engineering departments, so its fit with hospital-side HTM is partial and indirect.
DDISmart's REGai agentic AI platform runs autonomous agents that execute regulatory processes, monitor status, escalate issues, and learn over time, automating dossier compilation, labeling QC, and CER updates.
DDISmart supports regulatory workflows across FDA, EU MDR, and ISO 13485, including technical files, labeling/IFU, UDI, and Clinical Evaluation Reports.
We cite a primary or named source for every claim on this page. How we evaluate →